Bottom line
How much do PHSYX and HRTS overlap?
62% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 69.7% of PHSYX's assets and 59.3% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
PHSYX holds far more positions (115 vs 45), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHSYX and HRTS have in common
| Holding | % of PHSYX | % of HRTS | Overlap |
|---|---|---|---|
| Eli Lilly & Co. | 13.15% | 11.52% | 11.52% |
| Johnson & Johnson | 8.46% | 3.59% | 3.59% |
| UnitedHealth Group, Inc. | 6.93% | 5.24% | 5.24% |
| AbbVie, Inc. | 6.05% | 2.40% | 2.40% |
| Novartis AG | 5.13% | 3.38% | 3.38% |
| Merck & Co., Inc. | 4.88% | 4.27% | 4.27% |
| AstraZeneca plc | 4.67% | 4.00% | 4.00% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.97% | 3.97% |
| Edwards Lifesciences Corp. | 2.80% | 1.75% | 1.75% |
| Gilead Sciences, Inc. | 2.63% | 3.43% | 2.63% |
| McKesson Corp. | 2.14% | 1.71% | 1.71% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.93% | 1.97% |
| Novo Nordisk A/S | 1.90% | 5.24% | 1.90% |
| Bristol-Myers Squibb Co. | 1.75% | 2.09% | 1.75% |
| Dexcom, Inc. | 1.64% | 1.92% | 1.64% |
| Amgen, Inc. | 1.11% | 1.91% | 1.11% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHSYX
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
- Roche Holding AG — 2.79%
- CVS Health Corp. — 2.74%
- Cardinal Health, Inc. — 2.12%
- Boston Scientific Corp. — 1.80%
- Hoya Corp. — 1.52%
- Putnam Short Term Investment Fund — 1.35%
- HCA Healthcare, Inc. — 1.18%
Only in HRTS
- Roche Holding AG — 4.50%
- Revolution Medicines Inc — 3.33%
- Danaher Corp — 2.66%
- Abbott Laboratories — 2.61%
- Bridgebio Pharma Inc — 2.59%
- Cytokinetics Inc — 2.52%
- Teva Pharmaceutical Industries — 2.06%
- Medtronic PLC — 1.88%
- Regeneron Pharmaceuticals Inc — 1.67%
Asset mix
| Asset type | PHSYX | HRTS |
|---|---|---|
| Stocks | 98.2% | 99.2% |
| Other | 1.4% | — |
| Cash & short-term funds | 0.6% | 0.7% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | PHSYX | HRTS |
|---|---|---|
| US | 76.2% | 74.9% |
| CH | 7.9% | 7.9% |
| DK | 2.4% | 7.0% |
| GB | 6.4% | 4.0% |
| FR | 3.2% | — |
| JP | 2.4% | 1.3% |
| IL | — | 2.1% |
| IE | — | 1.9% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PHSYX and HRTS overlap?
What stocks do PHSYX and HRTS have in common?
Should I own both PHSYX and HRTS?
Which holds more stocks, PHSYX or HRTS?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.